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1. Introduction
  The burden of malaria is great as it affects the development 
and general well-being of many people. The disease has 
spread globally owing mainly to the failure of vector control 
programmes and spread of resistance to chloroquine and 
other known antimalarial drugs[1]. This trend has led to 
the promotion of scientific investigation of medicinal 
plants, especially those used traditionally in the treatment 
of malaria. More efforts in this area are expected to come 
from Sub-Saharan Africa as it remains the place where the 
burden of malaria is greatest[2]. 
  Eleucine indica, L.Gaertn (Poaceae) is called nkimenang 
(Ibibios), and crowsfoot or goose grass (English). It is 
an annual growing to 0.45 m and is considered as an 
adventitious species that is native in the tropics and 
subtropical regions[3]. It is one of the medicinal plants 
used in the treatment of malaria fever among the Ibibios 
of Southern Nigeria. The whole plant decoction is used 
to treat malaria and to restore menstruation in females 
suffering from ammenorrhoea. The whole plant especially 
the root is depurative, diuretic, febrifuge and laxative. It 
is also used in the treatment of influenza, hypertension, 
oliguria and urinary retention as well as kidney problems 
in Trinidad and Tobago[4]. The plant has been reported to 
have phytochemical content of sterol glucoside forms and 
C-glycosyl-flavone possessing anti-inflammatory activities 
antibacterial, antioxidant and non-cytotoxic properties[5].
 This present work has therefore been conducted in order 
to ascertain whether the whole plant has the antimalarial 
potentials as claimed in its ethnomedicinal use in the 
treatment of malaria fever.
2. Materials and methods
2.1. Plant materials 
  The plant material (Eleucine indica) was collected in 
April 2009 from Uyo, Akwa Ibom State, Nigeria. The plant 
was identified and authenticated by Dr. (Mrs.) Margaret 
Bassey (a plant Taxonomist) in the Department of Botany 
and Ecological Studies, University of Uyo, where a voucher 
specimen (UUH1409) was deposited. The plant material was 
air-dried and then oven-dried at reduced temperature 
(35±2)℃. It was thereafter ground into powder and cold-
macerated in 70% ethanol for 72 h, and filtered. The filtrate 
was dried in vacuo using the rotary evaporator. 30 g of the 
dried extract was partitioned using various solvents such as 
n-hexane, chloroform, ethyl acetate, butanol and water to 
obtain their respective fractions. The crude extract and the 
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fractions were stored in a refrigerator at -4℃ until required 
for use. 
2.2. Phytochemical screening
  The extract was screened for bioactive ingredients such 
as saponins, alkaloids, tannins, phlobotannins, flavonoids, 
anthraquinones, and cardiac glycosides[6,7].
2.3. Animal stock
  Adult albino mice (20-28 g) were obtained from the Animal 
House of the University of Jos, Jos, Plateau State and 
maintained in the University of Uyo Animal House and fed 
with growers pellet Feed (Bendel Feeds and Flour mills Ltd, 
Edo State) with water given ad libitum. Approval for the use 
of animals in the study was obtained from the Animal Ethics 
Committee, Faculty of Pharmacy, University of Uyo, Uyo, 
Akwa Ibom State. 
2.4. Micro-organisms
  A chloroquine-sensitive strain of Plasmodium berghei 
berghei was obtained from National Institute of Medical 
Research in Lagos and maintained by subpassage in mice.   
2.5. Inoculum preparation     
  The parasitized blood donor with high parasitaemia was 
obtained by first anaesthetizing the mouse with chloroform, 
and through cardiac puncture blood was collected using 
sterile syringe into sterile heparinised bottles. The 
percentage parasitaemia was determined by counting the 
number of parasitized red blood cells against the total 
number of red blood cells. The desired volume of blood then 
obtained from the donor mouse was suitably diluted with 
sterile normal saline so that the final inoculum (0.2 mL) for 
each mouse contained the required number of parasitized 
red blood cells (that is 1.0×107 parasitized red blood cells). 
Therefore the 0.2 mL of the final inoculum did contain 1×107 
parasitized red blood cells which is the standard inoculum for 
the infection of a single mouse. 1 mL of the standard inoculum 
is expected to contain 5×107 parasitized red blood cells[8,9]. 
2.6. Drug administration
  Drugs (chloroquine, pyrimethamine, and artesunate), 
extract and all fractions used in this antimalarial work were 
administered through the oral route using stainless metallic 
feeding cannula.
  
2.7. Acute toxicological study
  Acute toxicological study was carried out to determine 
the median lethal dose (LD50) using the modified method of 
Miller and Tainter as described by Ali et al[10] and Nwafor et 
al[11].
2.8. Antiplasmodial activities of the extract  
2.8.1. Determination of suppressive activity of extract on early 
infection (4 - day test)
  To determine the suppressive activity of the extract, the 
method earlier described with modifications[12] was adopted. 
The mice were each inoculated on the first day (day 0), 
intraperitoneally with 0.2 mL of infected blood containing 
about 1×107 Plasmodium berghei berghei parasitized 
erythrocytes. The animals were then randomly divided into 
six groups of six mice each. After ten minutes, the mice 
in the first group were orally administered with 10 mL/kg 
of distilled water and served as control. Groups 2, 3, and 4 
received 200, 400 and 600 mg/kg of the extract orally. Group 
5 received chloroquine 5 mg/kg/day as positive control while 
group 6 was administered with 400 mg/kg of extract conjointly 
with chloroquine 5 mg/kg/day. The administration of extract 
and drug was continued daily for 4 days (D0-D3) between 
8:00 am and 9:00 am. On the fifth day (D4) thin blood films 
were made from tail blood obtained from each mouse. The 
films were thereafter stained with Leishman’s stain to reveal 
parasitized erythrocytes. The percentage parasitaemia was 
obtained by counting the number of parasitized red blood cells 
out of 500 erythrocytes in random fields of the microscope.
% Parasitaemia=
No. of parasitized RBC
Total No. of RBC counted
伊100
Average percentage chemosuppression was calculated as 
100伊
A-B
B
  Where, A is the average percentage parasitaemia 
in negative control group and B, average percentage 
parasitaemia in the test group.
2.8.2. Determination of repository/prophylactic activities of 
extract
  T h e  m e t h o d s  e a r l i e r  d e s c r i b e d  w i t h  s l i g h t 
modifications[12,13]  were used to assess the prophylactic 
activity of the extract. Mice were divided randomly into 6 
groups of six animals per group. Group 1 animals received 
distilled water10 mL/kg. Groups 2, 3 and 4 were administered 
with 200, 400 and 600 mg/kg of the extract orally. Group 5 
animals served as positive control and were administered 
with 1.2 mg/mg/day of pyrimethamine. Group 6 animals 
received 400 mg/kg of the extract and pyrimethamine 
(1.2 mg/kg/day). All the groups were treated for three 
consecutive days (D0-D2) and on day 4 (D3), the mice were 
intraperitorneally injected with 1.2 mL of injected blood that 
contained 1×107 Plasmodium berghei berghei parasitized red 
blood cells (RBCs). The level of parasitaemia was assessed 
using thin films obtained from tail blood of each mouse 72 h 
after parasite inoculation. Percentage parasitaemia and the 
average chemosuppression were calculated as stated above.
2.8.3. Determination of effect of extract on established 
infection (Curative or rane test)
  To assess the schizonticidal activity of the extract during 
established infection, the methods earlier described and 
modified[12,13] were used. Thirty-six mice were inoculated 
intraperitoneally with standard innoculum of 1×107 
Plasmodium berghei parasitized red blood cells on the first 
day (D0).72 h later, the mice were randomized into 6 groups 
of six animals per group. Group 1 received 10 mL/kg of 
distilled water. Groups 2, 3 and 4 animals were administered 
with 200, 400 and 600 mg/kg/day of the extract orally. 
Group 5 animals were administered with 5 mg/kg/day of 
chloroquine. Group 6 animals received 400 mg/kg of extract 
along with 5 mg/kg/day of chloroquine. All the drugs were 
administered to the animals once daily for 5 days. Tail blood 
samples from each mouse was collected daily for 5 days, 
stained with Leishman’s stain and thin films prepared were 
used to monitor the level of parasitaemia. The mean survival 
time (MST) of each group was determined over a period of 30 
days (D0-D29).
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MST =
No. of days survived
Total No. of days (30)
伊100
2.8.4. Evaluation of antiplasmodial activity of the fractions 
using 4-day test
  Using the method earlier described[12], various fractions of 
Eleucine indica (n-hexane, chloroform, ethylacetate, butanol, and 
aqueous) were administered orally at the dose of 400 mg/kg/day
to different groups of six mice per group 30 min after 
intraperitoneal injection of 0.2 mL of infected blood 
containing about 1×107 Plasmodium berghei berhei. The 
negative control group received 10 mL/kg of distilled water. 
The administration of fraction/distilled water was continued 
for 4 days (D0-D3). Thin films were prepared from tail blood 
of each mouse on the fifth day and the level of parasitaemia 
was determined by counting the number of parasitized 
red blood cells out of 500 RBCs in random field of the 
microscope. The average percentage chemosuppression was 
calculated as stated above.
2.9. Statistical analysis
  Results were expressed as multiple comparisons of 
Mean±SEM. Significance was determined using One-way 
Analysis of Variance (ANOVA) followed by Tukey-Kramer 
multiple comparison post test. A probability level of less 
than 5% was considered significant.
 
3. Results
  The median lethal dose (LD50) was determined to be
(2 090.00±0.01) mg/kg. The phytochemical screening of the 
extract showed that the following constituents were present: 
alkaloids, cardiac glycosides, tannins, flavonoids and 
simple sugar. Saponins, anthraquinones and phlobotannins 
were absent. In the suppressive test (Table 1), there was 
a dose-dependent decrease in the levels of parasitaemia 
following administration of the extract compared to control. 
This decrease was statistically significant (P<0.05-0.001). 
However, the suppressive effect was less when compared 
with the standard drug chloroquine. In the repository test 
(Table 2), the extract showed a dose-dependent decrease 
in parasitaemia and this decrease was significant(P<0.001) 
when compared to control. There was a progressive dose- 
and time-dependent reduction in parasitaemia when the 
extract was tested on established infection (Figure 1). The 
MST (Table 3) of extract-treated groups of mice were dose-
dependently and significantly longer (25.67-2.12 days - 
27.8-1.17 days) when compared to control but shorter when 
compared with standard drug chloroquine (29.00±0.00). The 
fraction having the highest chemosuppressive effect was 
ethyl acetate fraction (77.89%) as shown in Table 4.
Table 1
Suppressive activity of ethanolic extract of Eleucine indica (4-day test) (n=6).
Drug / extract Dose Parasitaemia % Chemosuppression
Distilled water  (Control) 10 mL 33.00依1.03 -
Extract 200 mg/kg 28.00依4.99 15.15
400 mg/kg 21.50依0.76* 34.85
600 mg/kg   11.66依2.88*** 64.67
Chloroquine 5.0 mg/kg     1.33依0.61*** 95.97
Chloroquine+Extract 5.0  mg/kg+400 mg/kg   15.66依2.51*** 52.55
Significance relative to control: *P < 0.05 ; **P < 0.01; ***P < 0.001. 
Table 2
Repository activity of ethanolic extract of Eleucine indica (n=6).
Drug / extract Dose Parasitaemia % Chemosuppression
Distilled water  (Control) 10 mL  14.50依0.12 -
Extract 200 mg/kg       9.66依0.11*** 33.38
400 mg/kg       9.16依0.15*** 36.83
600 mg/kg       6.33依1.23*** 56.34
Pyrimethamine 1.2 mg/kg      2.16依0.60*** 85.10
Pyrimethamine+Extract 1.2  mg/kg+400 mg/kg      1.66依0.42*** 88.55
Significance relative to control: ***P < 0.001.
Table 4
Antiplasmodial activities of fractions of Eleucine indica during 4 -day 
test (n=6).
Drug / extract Dose Parasitaemia % chemosuppression
Distilled water 10 mL 15.83依0.24
Aqueous 400 mg/kg      7.16依0.04*** 54.77
n-Hexane 400 mg/kg      7.00依0.07*** 55.78
Butanol 400 mg/kg      9.66依0.13*** 38.98
Chloroform 400 mg/kg      8.66依0.12*** 45.29
Ethylacetate 400 mg/kg      3.50依0.76*** 77.89
Artesunate 5 mg/kg      1.16依0.65*** 92.67
Significance relative to control:  ***P< 0.001. 
Table 3
MST of mice receiving various doses of ethanolic extract of Eleucine 
indica  (Mean依SEM, n=6).
Drug/extract Dose MST (days)
Distilled water 10 mL 13.33依3.18
Extract 200 mg/kg     25.67依2.12***
400 mg/kg     26.50依1.63***
600 mg/kg     27.83依1.17***
Chloroquine 5 mg/kg     29.00依0.00***
 Chloroquine+ Extract 5  mg/kg +400 mg/kg     28.33依0.67***
Significance relative to control: ***P< 0.001.
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Figure 1. Antiplasmodial activity of ethanolic extract of Eleucine 
indica during established infection (curative test).
CQ-chloroquine, EIE- Eleucine indica extract.
4. Discussion
  Based on this preliminary evaluation and screening of the 
antiplasmodial activity of the crude extract and fractions of 
Eleucine indica, the results showed that each of them had 
some degree of antiplasmodial activity against mice infected 
with Plasmodium berghei. The observed antiplasmodial 
activity may be associated with the presence of active 
compounds such as alkaloids and flavonoids. Alkaloids 
have been known to exhibit antiplasmodial potentials by 
blocking protein synthesis in Plasmodium falciparum[14-18]. 
Flavonoids have been reported to chelate with nucleic acid 
base pairing of the parasite[19].
  It has also been reported that the leaves of Eleucine indica 
contain phenolic, possess antibacterial and antioxidant 
acivities[5]. The antioxidant property of this plant may 
represent yet another mechanism that contributes to its 
antiplasmodial activity. These taken together, depict 
the wide range of antiparasitic, anti-inflammatory, and 
anticarcinogenic potentials of this plant. The fact that ethyl 
acetate fraction showed the highest chemosuppressive 
effect when compared with others suggests that the active 
ingredients of this plant responsible for its antimalarial 
activity may be localized here.
  The antiplasmodial activities of Eleucine indica extract and 
its fractions as observed in this work may, therefore, have 
resulted from one or more of these mechanisms.
  The results of this study justify as well as confirm its 
ethnomedicinal use in the treatment of malaria among 
the Ibibios of Southern Nigeria. Further study is, however, 
necessary to identify the active principles involved and to 
elucidate the cellular antiplasmodial mechanisms of action. 
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